共 11 条
[4]
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study[J] . T Vesikari,A Karvonen,R Prymula,V Schuster,JC Tejedor,R Cohen,F Meurice,HH Han,S Damaso,A Bouckenooghe.The Lancet . 2007 (9601)
[5]
Molecular epidemiology of astrovirus type 1 in Belém, Brazil, as an agent of infantile gastroenteritis, over a period of 18 years (1982–2000): Identification of two possible new lineages[J] . Yvone B. Gabbay,José Paulo G. Leite,Darleise S. Oliveira,Liliany S. Nakamura,Marcio R.T. Nunes,Joana D’Arc P. Mascarenhas,Marcos Brian Heinemann,Alexandre C. Linhares.Virus Research . 2007 (2)
[6]
Evaluation of Safety, Immunogenicity and Efficacy of an Attenuated Rotavirus Vaccine, RIX4414: A Randomized, Placebo-Controlled Trial in Latin American Infants[J] . Bélen Salinas,Irene Pérez Schael,Alexandre C. Linhares,Guillermo M. Ruiz Palacios,M Lourdes Guerrero,Juan Pablo Yarzábal,Yolanda Cervantes,SueAnn Costa Clemens,Silvia Damaso,Karin Hardt,Béatrice De Vos.The Pediatric Infectious Disease Journal . 2005 (9)
[8]
Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study[J] . Christopher JL Murray,Alan D Lopez.The Lancet . 1997 (9064)
[9]
Epidemiology of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children in the tokyo area[J] . Tatsuhiko Shinozaki,Kazuko Araki,Yasuko Fujita,Masaaki Kobayashi,Takeshi Tajima,Toshiaki Abe.Scandinavian Journal of Infectious Diseases . 1991 (5)
[10]
Molecular epidemi-ology of human astrovirus infections in Kolkata,India. Bhattacharva R,Sahoo GC,Navak MK,et al. infectGenet Evol . 2006